FDA-approved nasal spray helps patients with treatment-resistant depression

ABC News’ Ike Ejiochi follows two patients taking an FDA-approved esketamine nasal spray for their treatment-resistant depression to better understand the drug’s effects.

March 26, 2026

Top Stories

ABC News Live Presents